 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/16/2024 |
$2.07 |
$2.29 |
$2.03 |
$2.08 |
13.20K | | 04/17/2024 |
$2.10 |
$2.11 |
$1.94 |
$1.96 |
32.00K | | 04/18/2024 |
$2.00 |
$2.07 |
$1.96 |
$1.97 |
10.50K | | 04/19/2024 |
$1.96 |
$2.07 |
$1.96 |
$1.98 |
7.80K | | 04/22/2024 |
$2.00 |
$2.05 |
$1.91 |
$1.98 |
8.70K |
|
|
| Can-Fite Biopharma is a clinical-stage biopharmaceutical company focused on developing orally bioavailable small molecule therapeutic products for the treatment of cancer, liver, inflammatory diseases, COVID-19 and erectile dysfunction. Co. also co-develops formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. Co.'s platform technology utilizes the Gi protein associated A3 adenosine receptor, or A3AR, as a therapeutic target. Co.'s pipeline of drug candidates are synthetic, agonists and allosteric modulators, or ligands or molecules that initiate molecular events when binding with target proteins, targeting the A3AR. | |
|
Can-Fite Biopharma (CANF) has the following price history information. Looking back at CANF historical stock prices for the last five trading days, on April 16, 2024, CANF opened at $2.07, traded as high as $2.29 and as low as $2.03, and closed at $2.08. Trading volume was a total of 13.20K shares. On April 17, 2024, CANF opened at $2.10, traded as high as $2.11 and as low as $1.94, and closed at $1.96. Trading volume was a total of 32.00K shares. On April 18, 2024, CANF opened at $2.00, traded as high as $2.07 and as low as $1.96, and closed at $1.97. Trading volume was a total of 10.50K shares. On April 19, 2024, CANF opened at $1.96, traded as high as $2.07 and as low as $1.96, and closed at $1.98. Trading volume was a total of 7.80K shares. On April 22, 2024, CANF opened at $2.00, traded as high as $2.05 and as low as $1.91, and closed at $1.98. Trading volume was a total of 8.70K shares.
CANF Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Can-Fite Biopharma shares, starting with a $10,000 purchase of CANF, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/24/2014 |
|
| End date: |
04/22/2024 |
|
| Start price/share: |
$796.50 |
|
| End price/share: |
$1.98 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-99.75% |
|
| Average Annual Total Return: |
-45.09% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$24.88 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 04/16/2024 | $2.08 | | 04/17/2024 | $1.96 | | 04/18/2024 | $1.97 | | 04/19/2024 | $1.98 | | 04/22/2024 | $1.98 |
|
|
